Ionis Pharmaceuticals, Inc. (IONS)
62.03
+2.29
(+3.83%)
USD |
NASDAQ |
Aug 24, 16:00
61.98
-0.05
(-0.08%)
After-Hours: 20:00
Ionis Pharmaceuticals Debt to Equity Ratio : 4.978 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.978 |
| March 31, 2026 | 5.310 |
| December 31, 2025 | 5.345 |
| September 30, 2025 | 3.315 |
| June 30, 2025 | 3.126 |
| March 31, 2025 | 4.116 |
| December 31, 2024 | 3.329 |
| September 30, 2024 | 2.996 |
| June 30, 2024 | 7.497 |
| March 31, 2024 | 6.641 |
| December 31, 2023 | 5.088 |
| September 30, 2023 | 6.261 |
| June 30, 2023 | 4.692 |
| March 31, 2023 | 3.853 |
| December 31, 2022 | 2.39 |
| September 30, 2022 | 2.111 |
| June 30, 2022 | 2.006 |
| March 31, 2022 | 1.765 |
| December 31, 2021 | 1.621 |
| September 30, 2021 | 2.463 |
| June 30, 2021 | 2.249 |
| March 31, 2021 | 1.382 |
| December 31, 2020 | 1.264 |
| September 30, 2020 | 0.5933 |
| June 30, 2020 | 0.5876 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5872 |
| December 31, 2019 | 0.5353 |
| September 30, 2019 | 0.5046 |
| June 30, 2019 | 0.5335 |
| March 31, 2019 | 0.5532 |
| December 31, 2018 | 0.6171 |
| September 30, 2018 | 0.8988 |
| June 30, 2018 | 0.8989 |
| March 31, 2018 | 2.039 |
| December 31, 2017 | 2.162 |
| September 30, 2017 | 1.941 |
| June 30, 2017 | 2.802 |
| March 31, 2017 | 2.953 |
| December 31, 2016 | 5.917 |
| September 30, 2016 | 3.547 |
| June 30, 2016 | 4.361 |
| March 31, 2016 | 3.028 |
| December 31, 2015 | 2.396 |
| September 30, 2015 | 1.924 |
| June 30, 2015 | 1.555 |
| March 31, 2015 | 1.676 |
| December 31, 2014 | 1.776 |
| September 30, 2014 | 0.6809 |
| June 30, 2014 | 0.6376 |
| March 31, 2014 | 0.6234 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Biogen, Inc. | 0.4433 |
| BridgeBio Pharma, Inc. | -1.353 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.995B |
| Total Liabilities (Quarterly) | 2.555B |
| Shareholders Equity (Quarterly) | 439.74M |
| Current Ratio | 7.893 |
| Net Debt Paydown Yield | -0.35% |